Bioengineering Laboratories joined the 10th Congress of the Vascular Access Society in Ljubljana (Slovenia), to present the breakthrough development of a novel, revolutionary vascular access made of silk fibroin and SilkothaneTM.
BEL’S innovative, patent pending technology is based on the electrospinning of silk fibroin and SilkothaneTM, to create a semi-degradable vascular access that encompasses the remodeling capabilities of native fistulae as well as the controlled mechanical properties of synthetic grafts.
http://www.vas2017.org/